Friction and trauma in the urethra are persistent and universal problems.
Introducing Proluma
Proluma’s patented design:
- Works indefinitely – There are no coatings or lubricants to wear off.
- Reduces Urethral Irritation, Inflammation, and Trauma – Friction and abrasion are practically eliminated.
- Potentially Decreases Bacterial Migration – Proluma’s unique design can potentially impede bacterial migration and colonization that can cause CAUTI.
Our Team
Troy Ziegler, CEO
CEO and COO of multiple medical technology startups including Resoundant (successful Mayo Clinic startup) and Softscope (acquired by FujiFilm Medical Systems). Former Entrepreneur in Residence at Mayo Clinic. US Air Force Academy (BSc), MIT Sloan School (MBA).
Mathieu Massicotte, MD, Founder, Chief Science Officer and Clinical Advisor
Yale School of Medicine, residency at Mass General, Boston Children’s, and Lahey Clinic. Currently Dir. Community Urology, Mass General Dept. of Urology. Inventor of multiple patented medical devices.
Peter Massicott, MD, MSc., Co-Founder and Board Member
Georgetown Medical School, residency University of N.C., Chapel Hill. Internist at Harvard University Health Services. Currently Dir. Medical Area Branch of Harvard University Health Services at Harvard Medical School. Member Harvard Medical School IRB.
Mark Solakian, J.D., Corporate Counsel Wilson Sonsini Goodrich & Rosati
Mark has an extensive background in venture capital financings, technology transactions, strategic alliances, corporate governance, mergers and acquisitions, and public, private equity and debt offerings.
Contact Us
We’re here to answer your questions